COR - CIK 0001140859
Cencora, Inc. trades as COR and has a market capitalization of $54.73 B, making it the #302 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $321.33B, up 9.3% from the prior year and net income of $1.55B. This page tracks Cencora, Inc. through 2,538 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Cencora, Inc.'s revenue grew from $146.85B to $321.33B, a compound annual growth rate of 9.1%. Net profit margin compressed from 1.0% to 0.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
| SCHEDULE 13G | - | 2026-04-29 |
| Insider trade | 4 | 2026-04-02 |
| SCHEDULE 13G/A | - | 2026-03-26 |
The largest companies sharing Cencora, Inc.'s SEC industry classification (wholesale-drugs, proprietaries & druggists' sundries).
Cencora, Inc. (COR) has a market capitalization of $54.73 B as of 2026-06-10, ranking #302 among US-listed companies.
Cencora, Inc. reported revenue of $321.33B for fiscal year 2025, an increase of 9.3% year over year.
Yes. Cencora, Inc. reported net income of $1.55B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.